Antibodies against granulocyte–macrophage colony stimulating factor (GM-CSF) in particular have been extensively characterized and have been designated a diagnostic factor for the respiratory disease pulmonary alveolar proteinosis, which arises from macrophage dysfunction caused by GM-CSF suppression17,18. Here, CSF2 is linked to respiratory system disorder.